MICHAEL RANKINS: Open Payments
NPI 1285771949 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$248 in 5 payments from 5 companies in 2025. Trend: 2023 $38 · 2024 $57 · 2025 $248
Food & beverage: $248
| Company | Payments | Amount |
|---|---|---|
| Atland Pharmaceuticals, LLC | 1 | $178 |
| Kerecis Limited | 1 | $26 |
| Boston Scientific Corporation | 1 | $16 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $14 |
| ERMI LLC | 1 | $14 |
Products named: ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE, Kerecis SurgiClose, WaveWriter Alpha Prime 16, JOURNAVX.
Industry payments across AL — which companies pay providers there.
